SEC EDGAR · Insider purchase
OBIO: Taylor Andrew Lawrence reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow OBIO- Became public
- Nov 9, 2026, 4:30 PM EST
- Event / period date
- Nov 9, 2026
- Collected
- Nov 9, 2026, 4:37 PM EST
Why this is connected
This filing identifies Orchestra BioMed Holdings, Inc. as the issuer of the security. The company's SEC identifier connects it to OBIO.
Reported transactions
Taylor Andrew Lawrence (Chief Financial Officer)
1,000 shares · Common Stock, par value $0.0001 per share
Nov 9, 2026 · $5.00 per share
Value calculated from the reported shares and prices: $5,000.00.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-09</periodOfReport>
<notSubjectToSection16>0</notSubjectToSection16>
<issuer>
<issuerCik>0001814114</issuerCik>
<issuerName>Orchestra BioMed Holdings, Inc.</issuerName>
<issuerTradingSymbol>OBIO</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001723889</rptOwnerCik>
<rptOwnerName>Taylor Andrew Lawrence</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>C/O ORCHESTRA BIOMED HOLDINGS, INC.</rptOwnerStreet1>
<rptOwnerStreet2>150 UNION SQUARE DRIVE</rptOwnerStreet2>
<rptOwnerCity>NEW HOPE</rptOwnerCity>
<rptOwnerState>PA</rptOwnerState>
<rptOwnerZipCode>18938</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>1</isOfficer>
<isTenPercentOwner>0</isTenPercentOwner>
<isOther>0</isOther>
<officerTitle>Chief Financial Officer</officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock, par value $0.0001 per share</value>
</securityTitle>
<transactionDate>
<value>2026-11-09</value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
<footnoteId id="F1"/>
</transactionCoding>
<transactionTimeliness></transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>1000</value>
</transactionShares>
<transactionPricePerShare>
<value>5.00</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>590989</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share.</footnote>
</footnotes>
<ownerSignature>
<signatureName>/s/ Andrew Taylor</signatureName>
<signatureDate>2026-11-09</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.